Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-1,415
Closed -$250K 1119
2017
Q3
$242K Sell
1,415
-825
-37% -$126K ﹤0.01% 958
2017
Q2
$292K Buy
2,240
+400
+22% +$53K 0.01% 869
2017
Q1
$244K Buy
+1,840
New +$226K ﹤0.01% 969
2016
Q3
Sell
-6,540
Closed -$692K 992
2016
Q2
$649K Buy
+6,540
New +$636K 0.02% 530
2015
Q2
Sell
-2,448
Closed -$247K 1095
2015
Q1
$247K Sell
2,448
-3,650
-60% -$384K 0.01% 902
2014
Q4
$658K Buy
6,098
+325
+6% +$33K 0.01% 823
2014
Q3
$570K Buy
5,773
+2,400
+71% +$226K 0.01% 935
2014
Q2
$315K Sell
3,373
-15,200
-82% -$1.31M 0.01% 1078
2014
Q1
$1.73M Buy
+18,573
New +$1.65M 0.03% 468

Other funds holding ASML

Integral Derivatives's ASML Position: Q4 2017 in Review

Integral Derivatives sold out of ASML (ASML) in Q4 2017, closing a stake of 1,415 shares — an estimated $250K sold.

Integral Derivatives first reported a position in ASML in Q1 2014 and held it in 9 quarters. The position peaked at $1.73M in Q1 2014. 298 funds tracked by Wall St. Rank hold ASML as of Q4 2017.

  • Integral Derivatives reported no remaining ASML position as of Q4 2017 after selling out during the quarter.
  • Integral Derivatives sold 1,415 ASML shares in Q4 2017, an estimated $250K.
  • Integral Derivatives first reported a position in ASML in Q1 2014 and held it in 9 quarters.
  • Integral Derivatives's ASML position peaked at $1.73M in Q1 2014.
  • 298 funds tracked by Wall St. Rank held ASML as of Q4 2017.

Based on Integral Derivatives's 13F filing for Q4 2017, filed 14 Feb 2018.